|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 489/08 | |
| A61K 31/485 | |||
| A61K 9/70 | |||
| A61K 31/4468 | |||
| A61K 45/06 | |||
| A61P 25/04 | |||
| A61P 29/00 |
| (11) | Number of the document | 3352823 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16849844.2 |
| Date of filing the European patent application | 2016-09-26 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053699 |
| Date | 2016-09-26 |
| (87) | Number | WO 2017/053938 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201562222924 P | 2015-09-24 | US |
| (72) |
ZAMLOOT, Michael, US
BARBIER, Remi, US
FRIEDMANN, Nadav, US
SRIRAMBHATLA, Vijay, GB
WATT, Stephen, GB
|
| (73) |
Pain Therapeutics, Inc.,
7801 N. Capital of Texas Highway Suite 260, Austin, TX 78731,
US
Zamloot, Michael, 1036 Liberty Park Drive 50, Austin, TX 78746, US |
| (54) | CRYSTALLINE SALTS OF NALOXONE AND NALTREXONE |
| CRYSTALLINE SALTS OF NALOXONE AND NALTREXONE |